Trial Profile
A Randomized, Placebo-Controlled, Double-Blind Study to Evaluated the Efficacy and Safety of an Intra-Articular Injection of AMPION in Adults With Pain Due to Osteoarthritis of the Knee
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 11 Aug 2022
Price :
$35
*
At a glance
- Drugs DMI 9523 (Primary)
- Indications Osteoarthritis
- Focus Registrational; Therapeutic Use
- Acronyms PIVOT
- Sponsors Ampio Pharmaceuticals
- 17 Jun 2021 According to an Ampio Pharmaceuticals media release, pooled results from AP-003-A, AP-003-B, and AP-004 trials had been published in Orthopedics 2018.
- 17 Jun 2021 Pooled results from AP-003-A, AP-003-B, and AP-004 trials presented in an Ampio Pharmaceuticals media release.
- 22 Nov 2017 Pooled analysis of this and 2 other trials (see CT profiles 214957 and 225451) has been published in Orthopedics, according to an Ampio Pharmaceuticals media release.